Photocatalytic generation of singlet oxygen for air purification

Patent metadata

Field	Value
Publication number	US-12343455-B2
Application number	US-202117524654-A
Country	US
Kind code	B2
Filing date	Nov 11, 2021
Priority date	Nov 12, 2020
Publication date	Jul 1, 2025
Grant date	Jul 1, 2025

Abstract

Aspects disclosed herein include a system for generating singlet oxygen in a gas, the system comprising: a substrate; and hexanuclear clusters operably immobilized on at least a portion of the substrate; wherein each hexanuclear cluster comprises a photosensitive octahedral core complex characterized by formula FX1a: M 6 X 8 (FX1a); wherein each M is independently Mo, W, or Re; wherein each X is independently a halide anion ligand; wherein the clusters are exposed to the gas and the gas comprises O 2 gas; wherein the clusters are exposed to a light; and wherein each hexanuclear cluster is a photosensitizer configured to generate the gaseous singlet oxygen when irradiated by the light in the presence of the O 2 gas.

First claim

We claim:

1. A system for generating singlet oxygen in a gas, the system comprising:
a substrate; and
hexanuclear clusters operably immobilized on at least a portion of the substrate;
wherein each of the hexanuclear clusters comprises a photosensitive octahedral core complex characterized by formula FX1a:
M 6 X 8   (FX1a);

wherein each M is W;
wherein each X is independently a halide anion ligand;

wherein the hexanuclear clusters are exposed to the gas and the gas comprises at least O 2 gas;
wherein the hexanuclear clusters are exposed to a light;
wherein each of the hexanuclear clusters is a photosensitizer configured to generate the gaseous singlet oxygen when irradiated by the light in the presence of the O 2 gas; and
wherein the hexanuclear clusters are immobilized on the surface of the substrate via non-covalent association between the hexanuclear clusters and silane linker groups, the silane linker groups being covalently attached to the surface of the substrate.

2. The system of claim 1 , wherein each of the hexanuclear clusters is independently neutral, cationic, or anionic; wherein each of the cationic clusters, if present, is charge-balanced with one or more counterions; and wherein each of the anionic clusters, if present, is charge-balanced with one or more counterions.

3. The system of claim 1 , wherein each of the hexanuclear clusters is independently characterized by formula FX2a, FX2b, or FX2c:
M 6 X 8 L 6   (FX2a);

M 6 X 8 L 4   (FX2b); or

M 6 X 8 L 2   (FX2c); wherein:

each M is W;
each X is independently a halide anion ligand; and
each L is independently an organic or inorganic monoanion ligand.

4. The system of claim 3 , wherein each L is independently Cl, Br, I, C, or O.

5. The system of claim 1 , wherein each of the hexanuclear clusters is independently characterized by formula FX2d, FX2e, or FX2f:
M 6 X 8 (L′) 6−   (FX2d);

M 6 X 8 (L′) 4−   (FX2e); or

M 6 X 8 (L′) 2−   (FX2f); wherein:

each M is independently W;
each X is independently a halide anion ligand; and
each L′ is independently one or more organic or inorganic monoanion and/or polyanion ligands.

6. The system of claim 1 , wherein each of at least a fraction of the hexanuclear clusters is independently a compound characterized by formula FX3a, FX3b, or FX3c:
(M 6 X 6 L 6 ) 2− (A C ) p 2+   (FX3a);

(M 6 X 8 L 4 )(A N ) n   (FX3b); or

(M 6 X 8 L 2 ) 2+ (A A ) m 2−   (FX3c); wherein:

each M is independently W;
each X is independently a halide anion ligand;
each L is independently an organic or inorganic monoanion;
p is 2 and each A C is independently a counterion being an organic or inorganic monocation or p is 1 and A C is a counterion being an organic or inorganic dication;
m is 2 and each A A is independently a counterion being an organic or inorganic monoanion or m is 1 and A A is a counterion being an organic or inorganic dianion; and
n is an integer selected from the range of 1 to 2 and A N is an organic or inorganic neutral Lewis base ligand.

7. The system of claim 6 , wherein each A N is independently selected from the group consisting of N, a substituted or unsubstituted pyridine, a substituted or unsubstituted amine, a substituted or unsubstituted methide, carbon monoxide, a substituted or unsubstituted triphenylphosphine, a substituted or unsubstituted triphenylarsine, a substituted or unsubstituted dimethylsulfide, a substituted or unsubstituted diemthylselenide, ammonia, and any combination thereof; and wherein each A C is independently selected from the group consisting of a metal monocation, NH 4+ , tetrabutylammonium, tetramethylammonium, tetraethylammonium and any combination thereof.

8. The system of claim 1 , wherein each of the hexanuclear clusters comprises a composition characterized by formula FX4:
M 6 X 12   (FX4); wherein:

each M is independently W; and
each X is independently a halide anion.

9. The system of claim 1 , wherein each X is Cl, Br, or I.

10. The system of claim 1 , wherein the substrate has a composition characterized as a metal oxide, nonmetal oxide, a polymer, a coordination polymer or polymeric material, an organofluoride material, an allotrope of carbon, or a combination of these.

11. The system of claim 1 , wherein the substrate comprises a plurality of carbon-fluoride bonds.

12. The system of claim 1 , wherein the substrate comprises metal oxide or non-metal oxide particles having the clusters operably connected or associated thereto.

13. The system of claim 1 , wherein the light comprises visible light, ultraviolet light, or any combination of these.

14. The system of claim 1 comprising one or more fans, one or more blowers, one or more compressors, one or more pumps, one or more fluid actuators or a combination of these for conveying the gas to the clusters and/or from the clusters.

15. The system of claim 1 , wherein the gas is air.

16. The system of claim 1 , wherein the system is integrated with an HVAC system, a room air circulation system, an air filtration system, a medical facility air cleaning system, a clean-room air cleaning system, a utensil disinfection system, or any combination of these.

17. The system of claim 1 , wherein each of the hexanuclear clusters includes monoatomic and/or polyatomic ligands coordinated with or bound to the metal atoms of the cluster.

18. The system of claim 1 , wherein each of the hexanuclear clusters is independently characterized by formula FX2g:
M 6 X 8 (L′)  (FX2g); wherein:

each M is independently W;
each X is independently a halide anion ligand; and
each L′ is independently one or more organic or inorganic monoanion and/or polyanion ligands.

19. A system for inactivation of pathogens via singlet oxygen, the system comprising:
a photosensitizing component for generating gaseous singlet oxygen, comprising:
a substrate; and
hexanuclear clusters operably immobilized on the substrate;
wherein each of the hexanuclear clusters comprises a photosensitive octahedral core complex characterized by formula FX1a:
M 6 X 8   (FX1a);

wherein each M is W; and
wherein each X is independently a halide anion;

a conveyed gas in gas-communication with the photosensitizing component;
wherein the hexanuclear clusters are exposed to the gas and the gas comprises at least O 2 gas;

a light source configured to emit a light onto the hexanuclear clusters, the light being capable of photoactivating the hexanuclear clusters;
wherein each of the hexanuclear clusters is a photosensitizer configured to generate the gaseous singlet oxygen when irradiated by the light in the presence of the O 2 gas; and
wherein the hexanuclear clusters are immobilized on the surface of the substrate via non-covalent association between the hexanuclear clusters and silane linker groups, the silane linker groups being covalently attached to the surface of the substrate.

20. The system of claim 19 being a system for inactivation of airborne pathogens or a system for inactivation of pathogens on a surface, wherein:
the conveyed gas comprises the airborne pathogens to inactivate the airborne pathogens in the gas via the gaseous singlet oxygen; or
the conveyed gas, having the generated gaseous singlet oxygen, flows from the photosensitizing component onto the surface and the conveyed gas comprises the generated gaseous singlet oxygen at the surface.

21. A method for generating gaseous singlet oxygen in a gas, the method comprising:
exposing he

Assignees

• California Inst Of Techn

Inventors

• Grubbs Robert H
• Blumenfeld Carl M
• Gray Harry B
• Rossman George R

Classifications

• B01J2235/00

  Indexing scheme associated with group B01J35/00, related to the analysis techniques used to determine the catalysts form or properties · CPC title

• B01J35/70

  characterised by their crystalline properties, e.g. semi-crystalline (catalysts comprising carbon B01J21/18; molecular sieves B01J29/00) · CPC title

• B01J35/39

  Photocatalytic properties · CPC title

• C01B13/02

  Preparation of oxygen (by liquefying F25J) · CPC title

• B01J2531/64

  Molybdenum · CPC title